Compile Data Set for Download or QSAR
Report error Found 473 of ic50 data for polymerid = 87
TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531223(US11208399, Example 4 | (R)-2-(4-Methyl-6-((1-meth...)
Affinity DataIC50: 0.400nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531296(US11208399, Example 53)
Affinity DataIC50: 0.400nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM65497(CC-220 (Compound 6) | US9694015, 6.4S)
Affinity DataIC50: 0.460nMT: 2°CAssay Description:The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a 20° C. freezer prio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531253(US11208399, Example 12)
Affinity DataIC50: 0.600nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531331(US11208399, Example 82)
Affinity DataIC50: 0.700nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531220(US11208399, Example 1 | (R)-2-(6-((1-Ethylpiperidi...)
Affinity DataIC50: 0.800nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531288(US11208399, Example 47)
Affinity DataIC50: 0.800nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531289(US11208399, Example 48)
Affinity DataIC50: 0.800nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531319(US11208399, Example 71)
Affinity DataIC50: 0.800nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531332(US11208399, Example 83a)
Affinity DataIC50: 0.800nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM77001(3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoin...)
Affinity DataIC50: 0.850nMT: 2°CAssay Description:The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a 20° C. freezer prio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531230(US11208399, Example 6)
Affinity DataIC50: 0.900nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531254(US11208399, Example 13)
Affinity DataIC50: 1.20nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531252(US11208399, Example 11)
Affinity DataIC50: 1.30nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531337(US11208399, Example 85b | 3-Methyl-2-(6-(((1R,2R,5...)
Affinity DataIC50: 1.30nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531291(US11208399, Example 49)
Affinity DataIC50: 1.60nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531354(US11208399, Example 94a | 2-(6-(((3S, 5S)-5-Fluoro...)
Affinity DataIC50: 1.60nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531339(US11208399, Example 86b | 2-(6-(((1S,2S,5S)-8-(2-H...)
Affinity DataIC50: 1.80nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531232(US11208399, Example 7)
Affinity DataIC50: 1.90nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531364(US11208399, Example 101 | (R)-2-(6-((1-Ethylpiperi...)
Affinity DataIC50: 1.90nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531292(US11208399, Example 50)
Affinity DataIC50: 2.30nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM695523(US12084416, Example 21)
Affinity DataIC50: 2.40nMAssay Description:THP1 monocytes were differentiated with PMA (100 ng/mL) and incubated at 37 deg C. for 20 hrs in presence of 5% CO2. 2×105 differentiated cells were ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531293(US11208399, Example 51)
Affinity DataIC50: 2.60nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531323(US11208399, Example 74)
Affinity DataIC50: 2.60nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM695530(US12084416, Example 91)
Affinity DataIC50: 2.90nMAssay Description:THP1 monocytes were differentiated with PMA (100 ng/mL) and incubated at 37 deg C. for 20 hrs in presence of 5% CO2. 2×105 differentiated cells were ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531224(US11208399, Example 5 | (R)-3-Methyl-2-(5-methyl-6...)
Affinity DataIC50: 3nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531282(US11208399, Example 41)
Affinity DataIC50: 3nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531279(US11208399, Example 39)
Affinity DataIC50: 3.20nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531286(US11208399, Example 45)
Affinity DataIC50: 3.20nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531350(US11208399, Example 92a | 2-(6-(((R)-1-((S)-2-Hydr...)
Affinity DataIC50: 3.30nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531318(US11208399, Example 70)
Affinity DataIC50: 3.5nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531351(US11208399, Example 92b | 2-(6-(((R)-1-((R)-2-Hydr...)
Affinity DataIC50: 3.60nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM695533(US12084416, Example 111)
Affinity DataIC50: 4.30nMAssay Description:THP1 monocytes were differentiated with PMA (100 ng/mL) and incubated at 37 deg C. for 20 hrs in presence of 5% CO2. 2×105 differentiated cells were ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531329(US11208399, Example 80)
Affinity DataIC50: 4.70nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM695535(US12084416, Example 127)
Affinity DataIC50: 5.60nMAssay Description:THP1 monocytes were differentiated with PMA (100 ng/mL) and incubated at 37 deg C. for 20 hrs in presence of 5% CO2. 2×105 differentiated cells were ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531310(US11208399, Example 64)
Affinity DataIC50: 5.90nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM695536(US12084416, Example 129)
Affinity DataIC50: 5.90nMAssay Description:THP1 monocytes were differentiated with PMA (100 ng/mL) and incubated at 37 deg C. for 20 hrs in presence of 5% CO2. 2×105 differentiated cells were ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531363(US11208399, Example 100 | (R)-3-Methyl-2-(5-methyl...)
Affinity DataIC50: 6nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM77015((R)-3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoi...)
Affinity DataIC50: 6.20nMT: 2°CAssay Description:The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a 20° C. freezer prio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531340(US11208399, Example 87a | 2-(6-(((3R,6R)-6-(Hydrox...)
Affinity DataIC50: 6.30nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531352(US11208399, Example 93a | 2-(6-(((3S,5S)-5-Fluorop...)
Affinity DataIC50: 6.60nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531280(US11208399, Example 40)
Affinity DataIC50: 6.80nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531311(US11208399, Example 65)
Affinity DataIC50: 7.40nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM695514(US12084416, Example 4)
Affinity DataIC50: 7.40nMAssay Description:THP1 monocytes were differentiated with PMA (100 ng/mL) and incubated at 37 deg C. for 20 hrs in presence of 5% CO2. 2×105 differentiated cells were ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531360(US11208399, Example 97 | (3S,5R)-5-((6-(2-Hydroxy-...)
Affinity DataIC50: 7.60nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM695526(US12084416, Example 63)
Affinity DataIC50: 8nMAssay Description:THP1 monocytes were differentiated with PMA (100 ng/mL) and incubated at 37 deg C. for 20 hrs in presence of 5% CO2. 2×105 differentiated cells were ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531302(US11208399, Example 56)
Affinity DataIC50: 8.30nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM695528(US12084416, Example 84)
Affinity DataIC50: 8.5nMAssay Description:THP1 monocytes were differentiated with PMA (100 ng/mL) and incubated at 37 deg C. for 20 hrs in presence of 5% CO2. 2×105 differentiated cells were ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM695539(US12084416, Example 144)
Affinity DataIC50: 8.60nMAssay Description:THP1 monocytes were differentiated with PMA (100 ng/mL) and incubated at 37 deg C. for 20 hrs in presence of 5% CO2. 2×105 differentiated cells were ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM695525(US12084416, Example 56)
Affinity DataIC50: 8.80nMAssay Description:THP1 monocytes were differentiated with PMA (100 ng/mL) and incubated at 37 deg C. for 20 hrs in presence of 5% CO2. 2×105 differentiated cells were ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

Displayed 1 to 50 (of 473 total ) | Next | Last >>
Jump to: